How big is the Europe Breast Cancer Screening Tests Market?

The Europe Breast Cancer Screening Tests Market size is expected to reach USD 0.83 billion in 2024 and grow at a CAGR of 8.68% to reach USD 1.26 billion by 2029. Read More

What is the current Europe Breast Cancer Screening Tests Market size?

In 2024, the Europe Breast Cancer Screening Tests Market size is expected to reach USD 0.83 billion. Read More

Who are the key players in Europe Breast Cancer Screening Tests Market?

Allengers, Myriad Genetics, Inc., Siemens Healthineers, Hologic Inc. and GE Healthcare are the major companies operating in the Europe Breast Cancer Screening Tests Market. Read More

What years does this Europe Breast Cancer Screening Tests Market cover, and what was the market size in 2023?

In 2023, the Europe Breast Cancer Screening Tests Market size was estimated at USD 0.76 billion. The report covers the Europe Breast Cancer Screening Tests Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Breast Cancer Screening Tests Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Europe Breast Cancer Screening Tests Companies

This report lists the top Europe Breast Cancer Screening Tests companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Europe Breast Cancer Screening Tests industry.